AI Proteins Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$41.5M
- Investors
-
6
AI Proteins General Information
Description
Operator of a protein engineering platform intended to create synthetic proteins for therapeutic development. The company offers artificial intelligence-based protein design and high-throughput drug discovery capabilities, enabling biotechnology and pharmaceutical companies to develop durable, specific, and optimized protein therapeutics for targeted medical applications.
Contact Information
Website
aiproteins.comCorporate Office
- 660 Beacon Street
- Floor 6
- Boston, MA 02215
- United States
Corporate Office
- 660 Beacon Street
- Floor 6
- Boston, MA 02215
- United States
AI Proteins Timeline
AI Proteins Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A) | 12-Nov-2025 | $41.5M | Completed | Pre-Clinical Trials | ||
| 3. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 2. Accelerator/Incubator | 01-May-2023 | $18.2M | Completed | Pre-Clinical Trials | ||
| 1. Seed Round | 11-Jan-2022 | $18.2M | $18.2M | Completed | Pre-Clinical Trials |
AI Proteins Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
AI Proteins Comparisons
Industry
Financing
Details
AI Proteins Competitors (4)
One of AI Proteins’s 4 competitors is Lila, a Venture Capital-Backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lila | Venture Capital-Backed | Seattle, WA | ||||
| Ordaos | Venture Capital-Backed | New York, NY | ||||
| Aktis Oncology | Formerly VC-backed | Boston, MA | ||||
| Mopac Biologics | Venture Capital-Backed | Seattle, WA |
AI Proteins Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
AI Proteins Patents
AI Proteins Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025255205-A1 | Synthetic cd123 binding proteins, manufacture, and uses thereof | Pending | 05-Jun-2024 | ||
| AU-2025236313-A1 | Synthetic cd16a binding proteins, manufacture, and uses thereof | Pending | 15-Mar-2024 | ||
| WO-2025193961-A1 | Synthetic cd16a binding proteins, manufacture, and uses thereof | Pending | 15-Mar-2024 | ||
| AU-2025235386-A1 | Synthetic lilrb4-binding proteins, manufacture, and uses thereof | Pending | 15-Mar-2024 | ||
| WO-2025193960-A1 | Synthetic lilrb4-binding proteins, manufacture, and uses thereof | Pending | 15-Mar-2024 | C07K14/70503 |
AI Proteins Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
AI Proteins Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Impact Assets | Impact Investing | Minority | ||
| Mission BioCapital | Venture Capital | Minority | ||
| Santé Ventures | Venture Capital | Minority | ||
| Cobro Ventures | Venture Capital | Minority | ||
| Lightchain Capital | Venture Capital | Minority |
AI Proteins FAQs
-
When was AI Proteins founded?
AI Proteins was founded in 2021.
-
Where is AI Proteins headquartered?
AI Proteins is headquartered in Boston, MA.
-
What is the size of AI Proteins?
AI Proteins has 34 total employees.
-
What industry is AI Proteins in?
AI Proteins’s primary industry is Drug Discovery.
-
Is AI Proteins a private or public company?
AI Proteins is a Private company.
-
What is the current valuation of AI Proteins?
The current valuation of AI Proteins is .
-
What is AI Proteins’s current revenue?
The current revenue for AI Proteins is .
-
How much funding has AI Proteins raised over time?
AI Proteins has raised $59.7M.
-
Who are AI Proteins’s investors?
Impact Assets, Mission BioCapital, Santé Ventures, Cobro Ventures, and Lightchain Capital are 5 of 6 investors who have invested in AI Proteins.
-
Who are AI Proteins’s competitors?
Lila, Ordaos, Aktis Oncology, and Mopac Biologics are competitors of AI Proteins.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
